Associations of isoprostanes-related oxidative stress with surrogate subclinical indices and angiographic measures of atherosclerosis

Coronary Artery Disease

Volumn 18, Issue 8, 2007, Pages 615-620

  Basarici, Ibrahim ^a   Altekin, Refik Emre ^a,b   Demir, Ibrahim ^a   Yilmaz, Huseyin ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Burdur State Hospital   (Turkey)

Author keywords

Carotid intima media thickness; Coronary angiography; Coronary artery disease; Isoprostanes; Subclinical atherosclerosis

Indexed keywords

8 ISOPROSTANE;

ADULT; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ECHOGRAPHY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ATHEROSCLEROSIS; CORONARY ANGIOGRAPHY; DINOPROST; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 40349092911     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3282f0efa5     Document Type: Article

References (32)

1. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation 2005; 112:3547-3553.
2. Faxon DP, Creager MA, Smith SC, Pasternak RC, Olin JW, Bettmann MA, et al. Atherosclerotic vascular disease conference: executive summary; atherosclerotic vascular disease conference proceeding for healthcare professionals from a special writing group of American Heart Association. Circulation 2004; 109:2595-2604.
3. Lekakis JP, Papamichael C, Papaioannou TG, Stamatelopoulos KS, Cimponeriu A, Protogerou AD, et al. Intima-media thickness score from carotid and femoral arteries predicts the extent of coronary artery disease. The Int J Cardiovasc Imag 2005; 21:495-501.
4. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range. Prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37:87-92.
5. Simon A, Chironi G, Levenson J. Performance of subclinical arterial disease detection as a screening test for coronary heart disease. Hypertension 2006; 48:392-396.
6. Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 2006; 13:129-142.
7. 2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28:505-513.
8. 2 alpha, a marker of oxidative stress, is increased in patients with acute myocardial infarction. Free Radic Res 2006; 40:385-391.
9. Vasalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 2004; 256:308-315.
10. Wang B, Pan J, Wang L, Zhu H, Yu R, Zou Y. Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis 2006; 184:425-430.
11. Friedwald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
12. Praticò D, Lawson JA, Rokach J, FitzGerald GA. The isoprostanes in biology and medicine. Trends Endocrinol Metabol 2001; 12:243-247.
13. 2-isoprostanes) are formed in-situ on phospholipids. Proc Natl Acad Sci U S A 1992; 89:10721-10725.
14. Montuschi P, Barnes PJ, Roberts LJ II. Isoprostanes: markers and mediators of oxidative stress. FASEB J 2004; 18:1791-1800.
15. Yura T, Fukunaga M, Khan R, Nassar GN, Badr KF, Montero A. Free radical generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int 1999; 56:471-478.
16. Stevuljevic JK, Memon L, Stefanovic A, Spasic S, Kalimanovska VS, Stanojevic NB, et al. Correlations of oxidative stress parameters and inflammation markers in coronary artery disease patients. Clin Biochem 2007; 40:181-187.
17. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104:2673-2678.
18. 2 as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 2004; 109:843-848.
19. Gross M, Steffes M, Jacobs DR Jr, Yu X, Lewis L, Lewis CE, et al. Plasma F2-isoprostane and coronary calcium score: the CARDIA Study. Clin Chem 2005; 51:125-131.
20. Drüeke T, Witko-Sarsat V, Massy Z, Descamps-Latscha B, Guerin AP, Marchais SJ, et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 2002; 106:2212-2217.
21. Ruiz MC, Medina A, Moreno JM, Gomez I, Ruiz N, Bueno P, et al. Relationship between oxidative stress parameters and atherosclerotic signs in the carotid artery of stable renal transplant patients. Transplant Proc 2005; 37:3796-3798.
22. Pawlak K, Pawlak D, Mysliwiec M. Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients. Atherosclerosis 2007; 190:199-204.
23. Pawlak K, Naumnik B, Brzosko S, Pawlak D, Mysliwiec M. Oxidative stress a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients. Am J Nephrol 2004; 24:154-161.
24. Zalba G, Beloqui O, José GS, Moreno MU, Fortuño A, Dĩez J. NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease. Arterioscler Thromb Vasc Biol 2005; 25:1452-1457.
25. Watanabe T, Yasunari K, Nakamura M, Maeda K. Carotid artery intima-media thickness and reactive oxygen species formation by monocytes in hypertensive patients. J Hum Hypertens 2006; 20:336-340.
26. Ashfaq S, Abramson JL, Jones DP, Rhodes SD, Weintraub WS, Hooper WC, et al. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol 2006; 47:1005-1011.
27. Liu ML, Ylitalo K, Salonen R, Salonen JT, Taskinen MR. Circulating oxidized low density lipoprotein and its association with carotid intima media thickness in asymptomatic members of familial combined hyperlipidemia families. Arterioscler Thromb Vasc Biol 2004; 24:1492-1497.
28. Sugiyama M, Ohashi M, Takase H, Sato K, Ueda R, Dohi D. Effects of atorvastatin on inflammation and oxidative stress. Heart Vessels 2005; 20:133-136.
29. Mintz GS, Painter JA, Pichard AD, Kent KM, Satler LF, Popma JJ, et al. Atherosclerosis in angiographically 'normal' coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995; 25:1479-1485.
30. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness consensus (2004-2006): an update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23:75-80.
31. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharret AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146:483-494.
32. 2α in humans. J Biol Chem 1996; 271:20617-20620.